Relmada Therapeutics Inc (NAS:RLMD)
$ 0.4257 -0.0263 (-5.82%) Market Cap: 12.85 Mil Enterprise Value: -40.48 Mil PE Ratio: 0 PB Ratio: 0.27 GF Score: 29/100

Relmada Therapeutics Inc (RLMD) Transcripts

    • 1